Navigation Links
Rusty worms in the brain
Date:3/5/2008

This release is available in German.

Iron is vital to human life; for example, it is a component of hemoglobin, the substance that makes our blood red and supplies our cells with oxygen. However, iron can also cause heavy damage; it is thought that iron deposits in the brain contribute to certain forms of neurodegenerative diseases such as Parkinsons, Huntington s, and Alzhiemers. A malfunction of the blood transporter transferrin may be to blame. A team led by Peter J. Sadler at the University of Warwick (Coventry, UK) and Sandeep Verma of the Indian Institute of Technology (Kanpur, India) has now been able to show that transferrin can clump together to form wormlike fibrils. As reported in the journal Angewandte Chemie, this process releases rustlike iron particles.

Within the body, iron is present in the form of iron ions with a threefold positive charge (Fe3+) and must always be well wrapped to prevent it from reacting with proteins and causing damage. In blood plasma, iron is carried in the pockets of the iron transport protein transferrin. It only gets unwrapped once it is inside special cellular organelles.

But things can go wrong in this system, as Sadler and his colleagues have now proven. The researchers deposited iron-loaded human transferrin onto various surfaces under conditions that emulate those in living organisms. By using microscopy and electron microscopy, the researchers showed that the proteins aggregate into long wormlike fibrils. These worms have a regular striped pattern; the narrow dark stripes contain something similar to rust. Within the fibrils, the iron ions are no longer properly enclosed; explains Sadler, instead, they aggregate into periodically arranged nanocrystals whose structure seems to be very similar to the iron oxide mineral lepidocrocite.

The researchers suspect that in certain forms of neurodegenerative disease, iron deposits may form in a similar fashion in the brain. Such iron crystals are highly reactive and could lead to the formation of toxic free radicals, which attack and destroy nerve cells. If this assumption can be verified in vivo, agents that hinder the aggregation of transferrin may be the foundation for a new family of drugs.


'/>"/>

Contact: Peter J. Sadler
p.j.sadler@warwick.ac.uk
44-247-652-3653
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. After more than 100 years apart, webworms devastate New Zealand parsnips
2. Snoozing worms help Penn researchers explain the evolution of sleep
3. Worms take the sniff test to reveal sex differences in brain
4. Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms
5. Scientists alter sexual orientation in worms
6. The myth of runners high revisited with brain imaging
7. Brains R Us: Neuroscience and education town hall
8. Advertisers, neuroscientists trace source of emotions in brain
9. Sex differences in the brains serotonin system
10. Book is the first high-resolution digital mouse brain atlas designed for Web applications
11. New MIT tool probes brain circuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... RESEARCH TRIANGLE PARK, N.C. , April 27, 2017 ... ) today announced that its Board of Directors authorized ... company,s common stock. This program will became effective immediately, ... may be made in the open market, accelerated share ... time as determined by United Therapeutics, management and in ...
(Date:4/27/2017)... ... April 27, 2017 , ... Oncolinx, a ... 43North Startup Competition, has truly taken their cancer research out of this world. ... experiments from Cape Canaveral to the International Space Station’s (ISS) U.S. National Laboratory, ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... provider for digital pathology, today announced their digital pathology technology has the potential ... provided by five medical centers in The Netherlands as part of the ...
(Date:4/27/2017)... ... 27, 2017 , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, ... LHON is a rare devastating genetic disease that leads to a sudden and rapid ... of 20 patients carrying 11778, 14484 and 3460 mutations and having experienced the onset ...
Breaking Biology Technology: